Skip to content

MHz-OCT

MHz-OCT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00005173
Enrollment
85
Registered
2013-07-26
Start date
2013-09-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H30-H36

Interventions

Group 1: In patients, who are imaged by standard OCT for retinal changes, additionally MHz OCT is applied. Group 2: Current generation standard OCT

Sponsors

Augenklinik der Ludwig-Maximilians-Universität
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Patients can be included, who need for diagnosis or follow-up a standard OCT • Men and women >18 years • Informed written consent

Exclusion criteria

Exclusion criteria: General: • No written informed consent; • age<18 years; • pregnancy of breast feeding; • patients with severely reduced health status; • patients unable to comply and in whom conventional OCT cannot be performed; • neurologic disease within the face/affecting the eye (e. g. facial palsy); • allergy against Polymethylmethacrylate (PMMA); Concomitant eye disease: • active inflammation and infections of the eye; • uncontrolled glaucoma; Previous therapies of the eye (e.g. laser or surgery) are no exclusion criteria.

Design outcomes

Secondary

MeasureTime frame
Sekundary outcomes are the effects of different recording and analysis protocols with MHz OCT for different diseases. Also as an explantory endpoint, potential requirements for the usability of the device are investigated.

Primary

MeasureTime frame
Primary endpoint is based on the comparison of OCT images, which are obtained by image analysis from MHz-OCT datasets, with OCT images from current generation OCT systems (e.g. Heidelberg Spectralis SD-OCT). The question to be answered is, if diagnostic quality of images from the fast 3D MHz-data set are equal or better than current standard SD-OCT technology for diseases of the vitreoretinal interface, within the retina and the choroid. Primary endpoint is defined as no difference in diagnostic clinical quality grading (Grading of "clinical diagnostic value") between MHz-OCT and standard OCT.

Countries

Germany

Contacts

Public ContactMarcus Kernt

Augenklinik der Ludwig-Maximilians Universität

marcus.kernt@med.uni-muenchen.de089-5160-3811

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026